The Biden administration said Friday it is targeting 15 drugs in the second-ever round of price negotiations under Medicare, with blockbuster drugs Ozempic and Wegovy topping the list. The list of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results